Rating History for Acer Therapeutics (ACER) by Roth/MKM

More Stocks Rated by Roth/MKM | Latest Ratings for ACER
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/31/2023 Jonathan Aschoff Downgrade Neutral
(Buy)		 1.50
(N/A)		 0.61
(0.90)		 47.54% Details